Rennova Health Enters into Preferred Provider Network Agreement with ACPN

Download as PDF

WEST PALM BEACH, Fla.-- Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that it has entered into a preferred provider network agreement with ACPN. Under the agreement, ACPN’s more than 24 million members across the U.S. and more than 750,000 international members now will have access to Rennova's industry-leading and high-complexity diagnostic testing laboratories.

“It is with great eagerness that we announce our new relationship with a company as innovative and committed to quality as Rennova Health,” said Seth Breeden, chief operating officer of ACPN. “Entering into agreements with companies such as Rennova continues to ensure that our members have access to the best care. We are very excited to now offer access to Rennova's cutting-edge diagnostic laboratory services through our provider network.”

“This agreement with ACPN supports our commitment to growth as a participating provider and will enable us to bill as an in-network provider,” said Seamus Lagan, CEO of Rennova Health, Inc. “In addition, with both national and international provider network contracts, our business will be significantly strengthened. As we move from fee-based to outcomes-based reimbursements, our mission of connecting as a preferred provider, along with our ability to provide more accessible and complete patient health records is key to our growth. Participating as a preferred provider is fundamental to providing the highest quality of care for our medical clients and their patients.”

About ACPN

ACPN is an independent, multi-specialty provider network accessed by over 1,400 payers that has developed proprietary network and technology for the purpose of achieving consistency in healthcare transactions, simplifying claims adjudication processes, creating reasonable reimbursement arrangements and establishing reliable healthcare access for all parties; providers, payers and patients. More than 24 million American’s and 750,000 international lives have access to ACPN’s network through a client base consisting of Insurance Carriers, Third Party Administrators, Health and Welfare Funds, Employer Groups and Self-Insured Health Plans.

For more information please contact ACPN’s COO, Seth Breeden, at sethbreeden@acpnusa.com or visit www.acpnusa.com.

About Rennova Health, Inc.

Rennova Health, Inc. provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcome. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare.

For more information about Rennova Health, Inc., visit www.rennovahealth.com.

Rennova Health Safe Harbor Statement

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

Rennova Health
Sebastien Sainsbury, 561-666-9818
ssainsbury@rennovahealth.com
or
Investors
LHA
Kim Golodetz, 212-838-3777
Kgolodetz@lhai.com
or
Bruce Voss, 310-691-7100
Bvoss@lhai.com

Source: Rennova Health, Inc.

Released April 20, 2016